Tripdatabase. (2026). How long should treatment with bevacizumab for degenerative maculopathy be monitored before determining it is ineffective, and what clinical symptoms should be assessed? Zenodo.
Chicago-Zitierstil (17. Ausg.)Tripdatabase. How Long Should Treatment with Bevacizumab for Degenerative Maculopathy Be Monitored Before Determining It Is Ineffective, and What Clinical Symptoms Should Be Assessed? Zenodo, 2026.
MLA-Zitierstil (9. Ausg.)Tripdatabase. How Long Should Treatment with Bevacizumab for Degenerative Maculopathy Be Monitored Before Determining It Is Ineffective, and What Clinical Symptoms Should Be Assessed? Zenodo, 2026.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.